228 related articles for article (PubMed ID: 834057)
1. In vitro evidence for increased cellular immunity to lung cancer antigen during Levamisole immunotherapy.
Urist MM; Boddie AW; Townsend CM; Holmes EC
J Thorac Cardiovasc Surg; 1977 Feb; 73(2):189-94. PubMed ID: 834057
[TBL] [Abstract][Full Text] [Related]
2. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
Olkowski ZL; McLaren JR; Skeen MJ
Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
[TBL] [Abstract][Full Text] [Related]
3. Immunologic defects in lung cancer patients.
Holmes EC; Golub SH
J Thorac Cardiovasc Surg; 1976 Feb; 71(2):161-8. PubMed ID: 1107678
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.
Wright PW; Hill LD; Peterson AV; Pinkham R; Johnson L; Ivey T; Bernstein I; Bagley C; Anderson R
Cancer Treat Rep; 1978 Nov; 62(11):1671-5. PubMed ID: 215304
[TBL] [Abstract][Full Text] [Related]
5. Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole.
Basch CM; Spitler LE; Engleman EG; Engleman EP
J Rheumatol; 1977; 4(4):377-88. PubMed ID: 604477
[TBL] [Abstract][Full Text] [Related]
6. [Levamisole as an immunostimulant in primary lung cancer].
Krzyśko R; Słowik-Gabryelska A
Pneumonol Pol; 1981 Jan; 49(1):29-34. PubMed ID: 7291005
[No Abstract] [Full Text] [Related]
7. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human hepatoma.
Lee C; Chen S; Lin T
Cancer Res; 1977 Mar; 37(3):918-21. PubMed ID: 189919
[TBL] [Abstract][Full Text] [Related]
8. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
9. Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate.
Ablin RJ; Bhatti RA; Guinan PD
Cancer Res; 1978 Nov; 38(11 Pt 1):3702-6. PubMed ID: 698929
[TBL] [Abstract][Full Text] [Related]
10. Reactivating effect of levamisole on cell-mediated immunity in gastrointestinal cancer patients.
Miwa H; Orita K
Acta Med Okayama; 1977 Oct; 31(5):325-9. PubMed ID: 146404
[TBL] [Abstract][Full Text] [Related]
11. Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer--immune responses.
Balaram P; Remani P; Padmanabhan TK; Vasudevan DM
Neoplasma; 1988; 35(6):617-25. PubMed ID: 3221935
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte responses of lung cancer patients to tumor-associated antigen measured by leucine incorporation.
Roth JA; Holmes EC; Boddie AW; Morton DL
J Thorac Cardiovasc Surg; 1975 Oct; 70(4):613-8. PubMed ID: 1177475
[TBL] [Abstract][Full Text] [Related]
13. Cancer immunotherapy with levamisole.
Miwa H; Orita K
Acta Med Okayama; 1978 Jul; 32(3):239-45. PubMed ID: 151489
[TBL] [Abstract][Full Text] [Related]
14. Time lapse cinematographic demonstration of humoral and cell mediated immunity in squamous cell carcinoma of the lung.
Vetterlein M; Auchmann M; Breit P; Cerni C; Micksche M; Wrba H
Osterr Z Onkol; 1976; 3(4):99-102. PubMed ID: 1037019
[TBL] [Abstract][Full Text] [Related]
15. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
Grosser N; Thomson DM
Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
[TBL] [Abstract][Full Text] [Related]
16. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
[TBL] [Abstract][Full Text] [Related]
17. Indirect leukocyte migration inhibition reactions to a 3-M KCl extract of lung adenocarcinoma by lung cancer patients.
Suslov I; McCoy JL; Herberman RB
J Natl Cancer Inst; 1981 Feb; 66(2):233-7. PubMed ID: 7005504
[TBL] [Abstract][Full Text] [Related]
18. Final results of a multicenter placebo-controlled levamisole study of resectable lung cancer.
Amery WK
Cancer Treat Rep; 1978 Nov; 62(11):1677-83. PubMed ID: 365323
[TBL] [Abstract][Full Text] [Related]
19. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
Robinson E; Haim N; Segal R; Veseley Z; Mekori T
Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
[TBL] [Abstract][Full Text] [Related]
20. The LMI test in colon, breast and lung cancer long survivors.
Fazio M; Calabrese F; Coluccia C; Giacomasso S; Casadio C; Mancuso M; Negri L; Mastromatteo V
Panminerva Med; 1992; 34(2):60-4. PubMed ID: 1408329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
